| Number of reported bleeds within 12 months prior to enrollment (median, Q1, Q3) | Naïve to damoctocog alfa pegol (N = 6) | Pre‐treated with damoctocog alfa pegol (N = 32) | Total (N = 38) |
|---|---|---|---|
| Total bleeds | 4 (2.0, 10.0) | 0.0 (0.0, 1.0) | 0.0 (0.0, 4.0) |
| Spontaneous | 3.5 (1.0, 10.0) | 0.0 (0.0, 0.0) | 0.0 (0.0, 1.0) |
| Trauma | 0.0 (0.0, 1.0) | 0.0 (0.0, 0.0) | 0.0 (0.0, 1.0) |
| Joint | 3.5 (1.0, 10.0) | 0.0 (0.0, 1.0) | 0.0 (0.0, 2.0) |
| Spontaneous joint | 3.0 (1.0, 10.0) | 0.0 (0.0, 1.0) | 0.0 (0.0, 1.0) |
| Trauma joint | 0.0 (0.0, 0.0) | 0.0 (0.0, 0.0) | 0.0 (0.0, 0.0) |
| Note: Patients were enrolled at their initial visit, at which baseline data was recorded. | |||